Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8955)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 21, 2021 (publication date) through Jul 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Imajo K, Tetlow L, Dennis A, Shumbayawonda E, Mouchti S, Kendall TJ, Fryer E, Yamanaka S, Honda Y, Kessoku T, Ogawa Y, Yoneda M, Saito S, Kelly C, Kelly MD, Banerjee R, Nakajima A. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort. World J Gastroenterol 2021; 27(7): 609-623 [PMID: 33642832 DOI: 10.3748/wjg.v27.i7.609] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i7/609.htm |
| Number | Citing Articles |
| 1 |
Anna Di Bartolomeo, Jacob George. Metabolic Steatotic Liver Disease. 2024; : 297 doi: 10.1016/B978-0-323-99649-5.00016-9
|
| 2 |
T. Waddell, A. Namburete, P. Duckworth, A. Fichera, A. Telford, H. Thomaides-Brears, D. J. Cuthbertson, M. Brady. Poor glycaemic control and ectopic fat deposition mediates the increased risk of non-alcoholic steatohepatitis in high-risk populations with type 2 diabetes: Insights from Bayesian-network modelling. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1063882
|
| 3 |
Alexandru Popa, Felix Bende, Roxana Șirli, Alina Popescu, Victor Bâldea, Raluca Lupușoru, Radu Cotrău, Renata Fofiu, Camelia Foncea, Ioan Sporea. Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A “Real-Life” Cohort Study. Diagnostics 2021; 11(5): 783 doi: 10.3390/diagnostics11050783
|
| 4 |
Franziska Lobig, Dhinagar Subramanian, Michael Blankenburg, Ankur Sharma, Archana Variyar, Oisin Butler. To pay or not to pay for artificial intelligence applications in radiology. npj Digital Medicine 2023; 6(1) doi: 10.1038/s41746-023-00861-4
|
| 5 |
Fernando Bril. Chronic Complications of Diabetes Mellitus. 2024; : 185 doi: 10.1016/B978-0-323-88426-6.00017-8
|
| 6 |
Hong Chang Tan, Elizabeth Shumbayawonda, Cayden Beyer, Lionel Tim-Ee Cheng, Albert Low, Chin Hong Lim, Alvin Eng, Weng Hoong Chan, Phong Ching Lee, Mei Fang Tay, Stella Kin, Jason Pik Eu Chang, Yong Mong Bee, George Boon Bee Goh, Jun Zhao. Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Elastography to Evaluate the Early Effects of Bariatric Surgery on Nonalcoholic Fatty Liver Disease. International Journal of Biomedical Imaging 2023; 2023: 1 doi: 10.1155/2023/4228321
|
| 7 |
Rebecca Bresnahan, Rui Duarte, James Mahon, Sophie Beale, Marty Chaplin, Devarshi Bhattacharyya, Rachel Houten, Katherine Edwards, Sarah Nevitt, Michelle Maden, Angela Boland. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
. Health Technology Assessment 2023; : 1 doi: 10.3310/KGJU3398
|
| 8 |
Osama Alzoubi, Ahmad Arar, Viraj Singh, Sukru M. Erturk, Ferenc Mozes, Michael Pavlides. MRI in liver cirrhosis. Portal Hypertension & Cirrhosis 2022; 1(1): 23 doi: 10.1002/poh2.6
|
| 9 |
James Neuberger, Owen Cain. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. Hepatic Medicine: Evidence and Research 2021; : 59 doi: 10.2147/HMER.S278076
|
| 10 |
Kento Imajo, Hidenori Toyoda, Satoshi Yasuda, Yasuaki Suzuki, Katsutoshi Sugimoto, Hidekatsu Kuroda, Tomoyuki Akita, Junko Tanaka, Yutaka Yasui, Nobuharu Tamaki, Masayuki Kurosaki, Namiki Izumi, Atsushi Nakajima, Takashi Kumada. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort. Clinical Gastroenterology and Hepatology 2022; 20(11): 2533 doi: 10.1016/j.cgh.2021.11.003
|
| 11 |
Naim Alkhouri, Mukesh Harisinghani. Letter to the Editor: Comparing quantitative MRI technologies in steatotic liver disease. Hepatology 2024; 79(4): E119 doi: 10.1097/HEP.0000000000000676
|
| 12 |
Ting Duan, Han-Yu Jiang, Wen-Wu Ling, Bin Song. Noninvasive imaging of hepatic dysfunction: A state-of-the-art review. World Journal of Gastroenterology 2022; 28(16): 1625-1640 doi: 10.3748/wjg.v28.i16.1625
|
| 13 |
Daisuke Morimoto-Ishikawa. 18. Quantitative Magnetic Resonance Imaging Technique in Abdomen: Current Status and Future Prospects. Japanese Journal of Radiological Technology 2023; 79(7): 719 doi: 10.6009/jjrt.2023-2224
|
| 14 |
Carolina Rio Bartulos, Thomas J. Vogl, Philipp Wiggermann. Neue MRT-Verfahren zur NASH-Diagnostik. Gastro-News 2023; 10(6): 46 doi: 10.1007/s15036-023-3332-x
|
| 15 |
Jiahui Li, Alina M. Allen, Meng Yin. Reply: Comparing quantitative MRI technologies in steatotic liver disease. Hepatology 2024; 79(4): E121 doi: 10.1097/HEP.0000000000000677
|
| 16 |
Kamil Janowski, Elizabeth Shumbayawonda, Lin Cheng, Caitlin Langford, Andrea Dennis, Matt Kelly, Maciej Pronicki, Wieslawa Grajkowska, Malgorzata Wozniak, Piotr Pawliszak, Sylwia Chełstowska, Elzbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha. Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94754-9
|
| 17 |
Kamil Janowski, Elizabeth Shumbayawonda, Matt Kelly, Carlos Ferreira, Maciej Pronicki, Wieslawa Grajkowska, Magdalena Naorniakowska, Piotr Pawliszak, Sylwia Chełstowska, Elżbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha. Quantitative MR in Paediatric Patients with Wilson Disease: A Case Series Review. Children 2022; 9(5): 613 doi: 10.3390/children9050613
|
| 18 |
Marcelo Kugelmas, Mazen Noureddin, Nadege Gunn, Kimberly Brown, Zobair Younossi, Manal Abdelmalek, Naim Alkhouri. The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis. Liver International 2023; 43(5): 964 doi: 10.1111/liv.15555
|
| 19 |
Kento Imajo, Yusuke Saigusa, Takashi Kobayashi, Koki Nagai, Shinya Nishida, Nobuyoshi Kawamura, Hiroyoshi Doi, Michihiro Iwaki, Asako Nogami, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Hiroyuki Kirikoshi, Satoshi Yasuda, Hidenori Toyoda, Hideki Hayashi, Shigehiro Kokubu, Daisuke Utsunomiya, Hirokazu Takahashi, Shinichi Aishima, Beom Kyung Kim, Nobuharu Tamaki, Satoru Saito, Masato Yoneda, Rohit Loomba, Atsushi Nakajima. M‐PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis. Hepatology Research 2023; 53(9): 844 doi: 10.1111/hepr.13927
|
| 20 |
Kevin Kim-Jun Teh, Jason Pik-Eu Chang, George Boon-Bee Goh. Comprehensive Guide to Hepatitis Advances. 2023; : 3 doi: 10.1016/B978-0-323-98368-6.00014-8
|
| 21 |
Rita Basu, Mazen Noureddin, Jeanne M. Clark. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers. Mayo Clinic Proceedings 2022; 97(9): 1700 doi: 10.1016/j.mayocp.2022.04.005
|
| 22 |
Anneli Andersson, Matt Kelly, Kento Imajo, Atsushi Nakajima, Jonathan A. Fallowfield, Gideon Hirschfield, Michael Pavlides, Arun J. Sanyal, Mazen Noureddin, Rajarshi Banerjee, Andrea Dennis, Stephen Harrison. Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. Clinical Gastroenterology and Hepatology 2022; 20(11): 2451 doi: 10.1016/j.cgh.2021.09.041
|
| 23 |
Shuang Zheng, Kan He, Lei Zhang, Mingyang Li, Huimao Zhang, Pujun Gao. Conventional and artificial intelligence-based computed tomography and magnetic resonance imaging quantitative techniques for non-invasive liver fibrosis staging. European Journal of Radiology 2023; 165: 110912 doi: 10.1016/j.ejrad.2023.110912
|
| 24 |
Shi Qi, Xiaodie Wei, Jinhan Zhao, Xinhuan Wei, Haiqing Guo, Jingxian Hu, Qiqige WuYun, Calvin Q. Pan, Nengwei Zhang, Jing Zhang. Performance of MAST, FAST, and MEFIB in predicting metabolic dysfunction‐associated steatohepatitis. Journal of Gastroenterology and Hepatology 2024; doi: 10.1111/jgh.16589
|
| 25 |
Marian A. Troelstra, Julia J. Witjes, Anne‐Marieke van Dijk, Anne L. Mak, Oliver Gurney‐Champion, Jurgen H. Runge, Diona Zwirs, Daniela Stols‐Gonçalves, Aelko H. Zwinderman, Marije ten Wolde, Houshang Monajemi, Sandjai Ramsoekh, Ralph Sinkus, Otto M. van Delden, Ulrich H. Beuers, Joanne Verheij, Max Nieuwdorp, Aart J. Nederveen, Adriaan G. Holleboom. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort. Journal of Magnetic Resonance Imaging 2021; 54(6): 1937 doi: 10.1002/jmri.27703
|
| 26 |
Jiahui Li, Xin Lu, Zheng Zhu, Kyle J. Kalutkiewicz, Taofic Mounajjed, Terry M. Therneau, Sudhakar K. Venkatesh, Yi Sui, Kevin J. Glaser, Safa Hoodeshenas, Armando Manduca, Vijay H. Shah, Richard L. Ehman, Alina M. Allen, Meng Yin. Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH. Hepatology 2023; 78(4): 1200 doi: 10.1097/HEP.0000000000000417
|
| 27 |
Monica A. Tincopa, Rohit Loomba. Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis. Seminars in Liver Disease 2024; doi: 10.1055/s-0044-1788277
|